• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素和孕激素受体在口腔癌中的表达

Estrogen and Progesterone hormone receptor expression in oral cavity cancer.

作者信息

Grimm M, Biegner T, Teriete P, Hoefert S, Krimmel M, Munz A, Reinert S

机构信息

Department of Oral and Maxillofacial Surgery, University Hospital Tuebingen, Osianderstrasse 2-8, 72076, Tuebingen, Germany,

出版信息

Med Oral Patol Oral Cir Bucal. 2016 Sep 1;21(5):e554-8. doi: 10.4317/medoral.21182.

DOI:10.4317/medoral.21182
PMID:27475696
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5005091/
Abstract

BACKGROUND

Recent studies have shown an increase in the incidence of oral squamous cell carcinoma (OSCC) in younger patients. The hypothesis that tumors could be hormonally induced during pregnancy or in young female patients without the well-known risk factors alcohol or tobacco abuse seems to be plausible.

MATERIAL AND METHODS

Estrogen Receptor alpha (ERα) and Progesterone Receptor (PR) expression were analyzed in normal oral mucosa (n=5), oral precursor lesions (simple hyperplasia, n=11; squamous intraepithelial neoplasia, SIN I-III, n=35), and OSCC specimen. OSCCs were stratified in a young female (n=7) study cohort and older patients (n=46). In the young female study cohort three patients (n=3/7) developed OSCC during or shortly after pregnancy. Breast cancer tissues were used as positive control for ERα and PR expression.

RESULTS

ERα expression was found in four oral precursor lesions (squamous intraepithelial neoplasia, SIN I-III, n=4/35, 11%) and in five OSCC specimen (n=5/46, 11%). The five ERα positive OSCC samples were older male patients. All patients within the young female study cohort were negatively stained for both ERα and PR.

CONCLUSIONS

ER expression could be regarded as a seldom risk factor for OSCC. PR expression seems to be not relevant for the development of OSCC.

摘要

背景

最近的研究表明,年轻患者口腔鳞状细胞癌(OSCC)的发病率有所上升。肿瘤可能在怀孕期间或年轻女性患者中由激素诱导产生,而这些患者没有众所周知的危险因素,如酗酒或吸烟,这一假设似乎是合理的。

材料与方法

分析雌激素受体α(ERα)和孕激素受体(PR)在正常口腔黏膜(n = 5)、口腔前驱病变(单纯增生,n = 11;鳞状上皮内瘤变,SIN I - III,n = 35)和OSCC标本中的表达。OSCC患者被分为年轻女性研究队列(n = 7)和老年患者队列(n = 46)。在年轻女性研究队列中,有3名患者(n = 3/7)在怀孕期间或产后不久发生了OSCC。乳腺癌组织用作ERα和PR表达的阳性对照。

结果

在4例口腔前驱病变(鳞状上皮内瘤变,SIN I - III,n = 4/35,11%)和5例OSCC标本(n = 5/46,11%)中发现了ERα表达。5例ERα阳性的OSCC样本均为老年男性患者。年轻女性研究队列中的所有患者ERα和PR染色均为阴性。

结论

ER表达可被视为OSCC的一个罕见危险因素。PR表达似乎与OSCC的发生无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5694/5005091/ea355f0f9cf7/medoral-21-e554-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5694/5005091/13c9ca570e3f/medoral-21-e554-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5694/5005091/ea355f0f9cf7/medoral-21-e554-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5694/5005091/13c9ca570e3f/medoral-21-e554-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5694/5005091/ea355f0f9cf7/medoral-21-e554-g002.jpg

相似文献

1
Estrogen and Progesterone hormone receptor expression in oral cavity cancer.雌激素和孕激素受体在口腔癌中的表达
Med Oral Patol Oral Cir Bucal. 2016 Sep 1;21(5):e554-8. doi: 10.4317/medoral.21182.
2
Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC.口腔鳞状细胞癌(OSCC)患者的血清维生素D水平以及口腔癌前病变和OSCC中维生素D受体的表达
Med Oral Patol Oral Cir Bucal. 2015 Mar 1;20(2):e188-95. doi: 10.4317/medoral.20368.
3
Expression of Estrogen Receptors in OSCC in Relation to Histopathological Grade.口腔鳞状细胞癌中雌激素受体表达与组织病理学分级的关系
Anticancer Res. 2015 Nov;35(11):5867-72.
4
Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.口腔鳞状细胞癌的谷氨酰胺分解与致癌作用
Eur Arch Otorhinolaryngol. 2016 Feb;273(2):495-503. doi: 10.1007/s00405-015-3543-7. Epub 2015 Feb 7.
5
Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium.人类分娩过程中的孕酮撤退和雌激素激活由子宫肌层中孕酮受体A的表达协调。
J Clin Endocrinol Metab. 2002 Jun;87(6):2924-30. doi: 10.1210/jcem.87.6.8609.
6
Apoptosis resistance-related ABCB5 and DNaseX (Apo10) expression in oral carcinogenesis.口腔癌发生过程中与凋亡抵抗相关的ABCB5和DNaseX(Apo10)表达
Acta Odontol Scand. 2015 Jul;73(5):336-42. doi: 10.3109/00016357.2014.961029. Epub 2014 Sep 19.
7
Serum levels of sex hormones and expression of their receptors in thyroid tissue in female patients with various types of thyroid neoplasms.不同类型甲状腺肿瘤女性患者血清性激素水平及其在甲状腺组织中受体的表达
Pathol Res Pract. 2014 Dec;210(12):830-5. doi: 10.1016/j.prp.2014.09.002. Epub 2014 Sep 18.
8
Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.孕酮通过快速激活蛋白激酶途径诱导孕酮受体基因(PGR)表达,这些途径是雌激素受体α(ER)和孕酮受体(PR)在ER/PR靶基因上协同基因组作用所必需的。
Steroids. 2016 Oct;114:48-58. doi: 10.1016/j.steroids.2016.09.004. Epub 2016 Sep 15.
9
Targeting thiamine-dependent enzymes for metabolic therapies in oral squamous cell carcinoma?靶向硫胺素依赖性酶用于口腔鳞状细胞癌的代谢疗法?
Clin Transl Oncol. 2016 Feb;18(2):196-205. doi: 10.1007/s12094-015-1352-5. Epub 2015 Jul 16.
10
Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer.雌激素受体β与雌激素受体α和孕激素受体共同表达,并与乳腺癌的淋巴结状态、分级及增殖率相关。
Am J Pathol. 2000 Jan;156(1):29-35. doi: 10.1016/s0002-9440(10)64702-5.

引用本文的文献

1
Graph attention networks for predicting drug-gene association of glucocorticoid in oral squamous cell carcinoma: A comparison with GraphSAGE.用于预测口腔鳞状细胞癌中糖皮质激素药物-基因关联的图注意力网络:与GraphSAGE的比较
PLoS One. 2025 Jul 3;20(7):e0327619. doi: 10.1371/journal.pone.0327619. eCollection 2025.
2
Evaluation and Correlation of 17β-Estradiol in Blood and Estrogen Receptor α (ERα) and Estrogen Receptor β(ER β) in Tissue of Oral Squamous Cell Carcinoma.口腔鳞状细胞癌组织中血液17β-雌二醇与雌激素受体α(ERα)及雌激素受体β(ERβ)的评估与相关性研究
Asian Pac J Cancer Prev. 2025 May 1;26(5):1735-1743. doi: 10.31557/APJCP.2025.26.5.1735.
3

本文引用的文献

1
Targeting thiamine-dependent enzymes for metabolic therapies in oral squamous cell carcinoma?靶向硫胺素依赖性酶用于口腔鳞状细胞癌的代谢疗法?
Clin Transl Oncol. 2016 Feb;18(2):196-205. doi: 10.1007/s12094-015-1352-5. Epub 2015 Jul 16.
2
Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?癌症代谢相关蛋白与口腔癌发生的关联——口腔鳞状细胞癌化学预防和代谢致敏的指征?
J Transl Med. 2014 Jul 21;12:208. doi: 10.1186/1479-5876-12-208.
3
Regulation of estrogen receptor α function in oral squamous cell carcinoma cells by FAK signaling.
Understanding the tumor microenvironment for personalized immunotherapy in early-onset head and neck squamous cell carcinoma.
了解早发性头颈部鳞状细胞癌个性化免疫治疗的肿瘤微环境。
Front Immunol. 2025 Jan 2;15:1522820. doi: 10.3389/fimmu.2024.1522820. eCollection 2024.
4
Effect of Oral Inflammatory Burden on Size and Stage of Oral Tongue Cancer.口腔炎症负担对舌癌大小和分期的影响。
Oral Dis. 2025 Jul;31(7):2084-2090. doi: 10.1111/odi.15227. Epub 2024 Dec 30.
5
The Estrogen-Autophagy Axis: Insights into Cytoprotection and Therapeutic Potential in Cancer and Infection.雌激素-自噬轴:对癌症和感染中细胞保护及治疗潜力的见解
Int J Mol Sci. 2024 Nov 22;25(23):12576. doi: 10.3390/ijms252312576.
6
Estrogen α and β Receptor Expression in the Various Regions of Resected Glioblastoma Multiforme Tumors and in an In Vitro Model.雌激素受体 α 和 β 在不同部位切除的多形性胶质母细胞瘤肿瘤组织和体外模型中的表达。
Int J Mol Sci. 2024 Apr 8;25(7):4130. doi: 10.3390/ijms25074130.
7
Relationship between Menopausal Hormone Therapy and Oral Cancer: A Cohort Study Based on the Health Insurance Database in South Korea.更年期激素治疗与口腔癌的关系:一项基于韩国健康保险数据库的队列研究。
J Clin Med. 2022 Oct 2;11(19):5848. doi: 10.3390/jcm11195848.
8
Hormone receptors AR, ER, PR and growth factor receptor Her-2 expression in oral squamous cell carcinoma: Correlation with overall survival, disease-free survival and 10-year survival in a high-risk population.口腔鳞状细胞癌中 AR、ER、PR 和生长因子受体 Her-2 的表达:高危人群中与总生存、无病生存和 10 年生存的相关性。
PLoS One. 2022 May 11;17(5):e0267300. doi: 10.1371/journal.pone.0267300. eCollection 2022.
9
Prognostic Significance of Estrogen Receptor Alpha in Oral Squamous Cell Carcinoma.雌激素受体α在口腔鳞状细胞癌中的预后意义
Cancers (Basel). 2021 Nov 17;13(22):5763. doi: 10.3390/cancers13225763.
10
High Expression of MTA1 Predicts Unfavorable Survival in Patients With Oral Squamous Cell Carcinoma.MTA1 高表达预示着口腔鳞状细胞癌患者的生存预后不良。
In Vivo. 2021 Jul-Aug;35(4):2363-2368. doi: 10.21873/invivo.12513.
黏着斑激酶信号对口腔鳞状细胞癌细胞中雌激素受体α功能的调控
Endocr Relat Cancer. 2014 Aug;21(4):555-65. doi: 10.1530/ERC-14-0102. Epub 2014 May 13.
4
Oral tongue squamous cell carcinoma in young women: a matched comparison-do outcomes justify treatment intensity?年轻女性口腔舌鳞状细胞癌:配对比较——治疗强度的结果是否合理?
ISRN Otolaryngol. 2014 Mar 10;2014:529395. doi: 10.1155/2014/529395. eCollection 2014.
5
Oestrogens and androgen receptors in oral squamous cell carcinoma.口腔鳞状细胞癌中的雌激素和雄激素受体。
Acta Odontol Scand. 2013 Nov;71(6):1513-9. doi: 10.3109/00016357.2013.775335. Epub 2013 Sep 25.
6
Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC.484 例口腔鳞状细胞癌患者的临床病理参数与预后的关系:微血管侵犯(V+)是口腔鳞状细胞癌患者总生存的独立预后因素。
Clin Transl Oncol. 2012 Nov;14(11):870-80. doi: 10.1007/s12094-012-0867-2. Epub 2012 Jul 19.
7
Unusual presentation of oral squamous cell carcinoma in a young woman.一名年轻女性口腔鳞状细胞癌的不寻常表现。
Sultan Qaboos Univ Med J. 2012 May;12(2):228-31. doi: 10.12816/0003118. Epub 2012 Apr 9.
8
Head and neck squamous cell carcinoma in pregnant women.头颈部鳞状细胞癌孕妇。
Head Neck. 2013 Mar;35(3):335-42. doi: 10.1002/hed.22973. Epub 2012 Mar 16.
9
Expression of sexual hormones receptors in oral squamous cell carcinoma.口腔鳞状细胞癌中性激素受体的表达。
Int J Immunopathol Pharmacol. 2011 Apr-Jun;24(2 Suppl):129-32. doi: 10.1177/03946320110240S222.
10
The different roles of ER subtypes in cancer biology and therapy.内质网亚型在癌症生物学和治疗中的不同作用。
Nat Rev Cancer. 2011 Jul 22;11(8):597-608. doi: 10.1038/nrc3093.